Crispo, J.A.G.; Farhat, N.; Fortin, Y.; Perez-Lloret, S.; Sikora, L.; Morgan, R.L.; Habash, M.; Gogna, P.; Kelly, S.E.; Elliott, J.;
et al. Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease. Brain Sci. 2024, 14, 776.
https://doi.org/10.3390/brainsci14080776
AMA Style
Crispo JAG, Farhat N, Fortin Y, Perez-Lloret S, Sikora L, Morgan RL, Habash M, Gogna P, Kelly SE, Elliott J,
et al. Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease. Brain Sciences. 2024; 14(8):776.
https://doi.org/10.3390/brainsci14080776
Chicago/Turabian Style
Crispo, James A. G., Nawal Farhat, Yannick Fortin, Santiago Perez-Lloret, Lindsey Sikora, Rebecca L. Morgan, Mara Habash, Priyanka Gogna, Shannon E. Kelly, Jesse Elliott,
and et al. 2024. "Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease" Brain Sciences 14, no. 8: 776.
https://doi.org/10.3390/brainsci14080776
APA Style
Crispo, J. A. G., Farhat, N., Fortin, Y., Perez-Lloret, S., Sikora, L., Morgan, R. L., Habash, M., Gogna, P., Kelly, S. E., Elliott, J., Kohen, D. E., Bjerre, L. M., Mattison, D. R., Hessian, R. C., Willis, A. W., & Krewski, D.
(2024). Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease. Brain Sciences, 14(8), 776.
https://doi.org/10.3390/brainsci14080776
